Rozerem Expedites Experts’ Dreams: Honoraria!
According to Daniel Carlat, MD, author of the The Carlat Psychiatry Report and the Carlat Psychiatry Blog, Takeda -- the folks that brought us the sleep aid Rozerem -- paid Gary...
Awards: POE vs. MM&M. I Pick Winners!
DTC Perspectives, a pharmaceutical industry trade publication that focuses entirely on consumer marketing, announced the winners of its sixth annual Perspectives On Excellence Awards (POEs) last night at the Awards Dinner...
A Milestone: The Five Hundredth Post! Thank You!
Today marks a milestone for Pharma Marketing Blog: the five hundredth -- more or less -- post (#500 is "Pharma Grapples with Barriers to Adopting Web 2.0")!It's a small accomplishment considering...
Pharma Grapples with Barriers to Adopting Web 2.0
Yesterday, I sat in at several presentations made at ExL's Digital Pharma conference in Princeton, NJ. Underlying practically every presentation and in my discussions with a few attendees, was the issue...
Off to Digital Pharma!
Today, I will be spending some time in Princeton, NJ attending ExL Pharma's Digital Pharma conference. I hope to see some of you there.The presentations I hope to attend include:How MDs...
Pfizer the Headless Chicken!
Pfizer Inc. Chief Executive Jeffrey Kindler's decision to scrap an unpopular drug bucked an unspoken industry rule, according to a Wall Street Journal article ("Pfizer Breaks With Norm by Scrapping Drug")....
Sermo CEO Talks About Pfizer Collaboration
Daniel Palestrant, M.D., Founder and Chief Executive Officer of Cambridge-based Sermo, Inc., was a guest on last week's Pharma Marketing Talk live podcast entitled "Collaborating with Online Physician Communities."Palestrant claims that...
Exubera: A Titanic Failure! What the survivors are saying.
The Wall Street Journal today characterized the failure of Exubera as "one of the drug industry's costliest failures ever." Mike Krensavage, an analyst at Raymond James & Associates, was quoted in...
Exubera Bong Bombs!
Pfizer announced that it will no longer market Exubera, an inhaled insulin device that it just began to promote heavily on TV."We made an important decision regarding Exubera, a product for...
Parick Clinton Speaks About Drug Safety and Has a Special Offer for You!
Patrick Clinton, Editor-in-Chief of Pharmaceutical Executive Magazine, was my guest today for a Pharma Marketing Talk podcast entitled "Pharma Business Strategies in Times of Change."You can Listen Online to the audio...
